Literature DB >> 20129921

Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature?

Pimonrat Ketsawatsomkron1, Christopher J Pelham, Séverine Groh, Henry L Keen, Frank M Faraci, Curt D Sigmund.   

Abstract

Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a ligand-activated transcription factor of the nuclear hormone receptor superfamily. Increasing evidence suggests that PPAR gamma is involved in the regulation of vascular function and blood pressure in addition to its well recognized role in metabolism. Thiazolidinediones, PPAR gamma agonists, lower blood pressure and have protective vascular effects through largely unknown mechanisms. In contrast, loss-of-function dominant-negative mutations in human PPAR gamma cause insulin resistance and severe early onset hypertension. Recent studies using genetically manipulated mouse models have begun to specifically address the importance of PPAR gamma in the vasculature. In this minireview, evidence for a protective role of PPAR gamma in the endothelium and vascular smooth muscle, derived largely from studies of genetically manipulated mice, will be discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20129921      PMCID: PMC2843178          DOI: 10.1074/jbc.R109.025031

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  PPAR gamma is required for placental, cardiac, and adipose tissue development.

Authors:  Y Barak; M C Nelson; E S Ong; Y Z Jones; P Ruiz-Lozano; K R Chien; A Koder; R M Evans
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Comparative actions of insulin sensitizers on ion channels in vascular smooth muscle.

Authors:  K Eto; Y Ohya; Y Nakamura; I Abe; M Fujishima
Journal:  Eur J Pharmacol       Date:  2001-06-29       Impact factor: 4.432

3.  Effect of ramipril on the incidence of diabetes.

Authors:  Jackie Bosch; Salim Yusuf; Hertzel C Gerstein; Janice Pogue; Patrick Sheridan; Gilles Dagenais; Rafael Diaz; Alvaro Avezum; Fernando Lanas; Jeffrey Probstfield; George Fodor; Rury R Holman
Journal:  N Engl J Med       Date:  2006-09-15       Impact factor: 91.245

4.  Increased expression of peroxisome proliferator-activated receptor-alpha and -gamma in blood vessels of spontaneously hypertensive rats.

Authors:  Q N Diep; E L Schiffrin
Journal:  Hypertension       Date:  2001-08       Impact factor: 10.190

5.  PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy.

Authors:  Robert A Hegele; Henian Cao; Christy Frankowski; Suresh T Mathews; Todd Leff
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

6.  Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma.

Authors:  Quy N Diep; Mohammed El Mabrouk; Jeffrey S Cohn; Dierk Endemann; Farhad Amiri; Agostino Virdis; Mario Fritsch Neves; Ernesto L Schiffrin
Journal:  Circulation       Date:  2002-05-14       Impact factor: 29.690

7.  Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells.

Authors:  Nanping Wang; Lynne Verna; Neng-Guin Chen; Jasmine Chen; Hongling Li; Barry Marc Forman; Michael B Stemerman
Journal:  J Biol Chem       Date:  2002-07-09       Impact factor: 5.157

8.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

9.  PPAR(gamma) agonist rosiglitazone improves vascular function and lowers blood pressure in hypertensive transgenic mice.

Authors:  Michael J Ryan; Sean P Didion; Satya Mathur; Frank M Faraci; Curt D Sigmund
Journal:  Hypertension       Date:  2004-01-26       Impact factor: 10.190

10.  Effect of peroxisome proliferator-activated receptor-alpha and -gamma activators on vascular remodeling in endothelin-dependent hypertension.

Authors:  Marc Iglarz; Rhian M Touyz; Farhad Amiri; Marie-France Lavoie; Quy N Diep; Ernesto L Schiffrin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-01       Impact factor: 8.311

View more
  29 in total

1.  Endothelial PPARγ (Peroxisome Proliferator-Activated Receptor-γ) Is Essential for Preventing Endothelial Dysfunction With Aging.

Authors:  T Michael De Silva; Ying Li; Dale A Kinzenbaw; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2018-05-07       Impact factor: 10.190

Review 2.  Protecting against vascular disease in brain.

Authors:  Frank M Faraci
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-02-18       Impact factor: 4.733

3.  Vinegar decreases blood pressure by down-regulating AT1R expression via the AMPK/PGC-1α/PPARγ pathway in spontaneously hypertensive rats.

Authors:  Lixin Na; Xia Chu; Shuo Jiang; Chunjuan Li; Gang Li; Ying He; Yuanxiu Liu; Ying Li; Changhao Sun
Journal:  Eur J Nutr       Date:  2015-10-18       Impact factor: 5.614

Review 4.  Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide.

Authors:  Noboru Toda; Tomio Okamura
Journal:  Pflugers Arch       Date:  2016-07-14       Impact factor: 3.657

5.  G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.

Authors:  Shuibang Wang; Keytam S Awad; Jason M Elinoff; Edward J Dougherty; Gabriela A Ferreyra; Jennifer Y Wang; Rongman Cai; Junfeng Sun; Anetta Ptasinska; Robert L Danner
Journal:  J Biol Chem       Date:  2015-06-23       Impact factor: 5.157

6.  Role of peroxisome proliferator-activated receptor-γ in vascular muscle in the cerebral circulation.

Authors:  T Michael De Silva; Mary L Modrick; Pimonrat Ketsawatsomkron; Cynthia Lynch; Yi Chu; Christopher J Pelham; Curt D Sigmund; Frank M Faraci
Journal:  Hypertension       Date:  2014-09-02       Impact factor: 10.190

Review 7.  Endothelial PPARγ Is Crucial for Averting Age-Related Vascular Dysfunction by Stalling Oxidative Stress and ROCK.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Md Jakaria; Abdullah Al Mamun; Kamal Niaz; Md Shah Amran; George E Barreto; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2019-05-04       Impact factor: 3.911

8.  Effect of olive oil phenolic compounds on the expression of blood pressure-related genes in healthy individuals.

Authors:  Sandra Martín-Peláez; Olga Castañer; Valentini Konstantinidou; Isaac Subirana; Daniel Muñoz-Aguayo; Gemma Blanchart; Sonia Gaixas; Rafael de la Torre; Magí Farré; Guillermo T Sáez; Kristina Nyyssönen; Hans Joachim Zunft; Maria Isabel Covas; Montse Fitó
Journal:  Eur J Nutr       Date:  2015-12-12       Impact factor: 5.614

9.  PPARγ regulates resistance vessel tone through a mechanism involving RGS5-mediated control of protein kinase C and BKCa channel activity.

Authors:  Pimonrat Ketsawatsomkron; Ramón A Lorca; Henry L Keen; Eric T Weatherford; Xuebo Liu; Christopher J Pelham; Justin L Grobe; Frank M Faraci; Sarah K England; Curt D Sigmund
Journal:  Circ Res       Date:  2012-09-07       Impact factor: 17.367

10.  Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.

Authors:  Christopher J Pelham; Pimonrat Ketsawatsomkron; Séverine Groh; Justin L Grobe; Willem J de Lange; Stella-Rita C Ibeawuchi; Henry L Keen; Eric T Weatherford; Frank M Faraci; Curt D Sigmund
Journal:  Cell Metab       Date:  2012-10-03       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.